S3844Temporary National Codes (Non-Medicare)
Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital,
Short description: Dna analysis deafness
- Effective date
- July 1, 2003
- Termination date
- —
Related codes (S-series)
S0012Butorphanol tartrate, nasalS0013Esketamine, nasal sprayS0014Tacrine hydrochloride, 10 mgS0017Injection, aminocaproic acidS0020Injection, bupivicaine hydroS0021Injection, cefoperazone sodS0023Injection, cimetidine hydrocS0028Injection, famotidine, 20 mgS0030Injection, metronidazoleS0032Injection, nafcillin sodiumS0034Injection, ofloxacin, 400 mgS0039Injection, sulfamethoxazole
Frequently asked questions
What is HCPCS code S3844?
S3844 is a HCPCS Level II code for Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital,.
What category is HCPCS code S3844 in?
S3844 falls under the Temporary National Codes (Non-Medicare) category of HCPCS Level II.
When did HCPCS code S3844 become effective?
S3844 has been effective since July 1, 2003, per CMS's quarterly HCPCS update.
HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.